Update on World Health Organization HIV Drug Resistance Prevention and Assessment Strategy: 2004-2011

被引：46

作者：

Jordan, M. R. ^{[1
,2
]}

Bennett, D. E. ^{[3
]}

Wainberg, M. A.

Havlir, D. ^{[4
]}

Hammer, S. ^{[5
]}

Yang, C. ^{[3
]}

Morris, L. ^{[6
]}

Peeters, M. ^{[7
,8
]}

Wensing, A. M. ^{[9
]}

Parkin, N. ^{[10
]}

Nachega, J. B. ^{[11
,12
]}

Phillips, A. ^{[13
]}

De Luca, A. ^{[14
,15
]}

Geng, E. ^{[4
]}

Calmy, A. ^{[16
,20
]}

Raizes, E. ^{[3
]}

Sandstrom, P. ^{[17
]}

Archibald, C. P. ^{[17
]}

Perriens, J.

McClure, C. M.

Hong, S. Y. ^{[2
]}

McMahon, J. H. ^{[2
,18
]}

Dedes, N. ^{[19
]}

Sutherland, D. ^{[17
]}

Bertagnolio, S.

机构：

[1] World Hlth Org, Dept HIV, CH-1211 Geneva 27, Switzerland

[2] Tufts Univ, Sch Med, Boston, MA 02111 USA

[3] US Ctr Dis Control & Prevent, Atlanta, GA USA

[4] Univ Calif San Francisco, San Francisco, CA 94143 USA

[5] Columbia Univ, Med Ctr, New York, NY USA

[6] Natl Inst Communicable Dis, AIDS Virus Res Unit, Johannesburg, South Africa

[7] Inst Rech Dev, UMI 233 TransVIHMI, Montpellier, France

[8] Univ Montpellier I, F-34006 Montpellier, France

[9] Univ Med Ctr Utrecht, Utrecht, Netherlands

[10] Data First Consulting, Belmont, CA USA

[11] Univ Stellenbosch, Cape Town, South Africa

[12] Johns Hopkins Bloomberg, Sch Publ Hlth, Baltimore, MD USA

[13] UCL, London WC1E 6BT, England

[14] Univ Cattolica Sacro Cuore, Inst Clin Infect Dis, Rome, Italy

[15] Siena Univ Hosp, Div Infect Dis, Siena, Italy

[16] Univ Hosp Geneva, Geneva, Switzerland

[17] Publ Hlth Agcy Canada, Ottawa, ON, Canada

[18] Alfred Hosp, Melbourne, Vic, Australia

[19] Int Treatment Preparedness Coalit, Bangkok, Thailand

[20] Med Sans Frontiere Access Campaign, Geneva, Switzerland

来源：

CLINICAL INFECTIOUS DISEASES | 2012年 / 54卷

基金：

比尔及梅琳达.盖茨基金会; 美国国家卫生研究院;

关键词：

EARLY-WARNING INDICATORS; ANTIRETROVIRAL THERAPY; VIROLOGICAL FAILURE; GENERIC PROTOCOL; PREGNANT-WOMEN; SURVEILLANCE; INDIVIDUALS; ADHERENCE; CLINICS; PREDICTORS;

D O I：

10.1093/cid/cis206

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The HIV drug resistance (HIVDR) prevention and assessment strategy, developed by the World Health Organization (WHO) in partnership with HIVResNet, includes monitoring of HIVDR early warning indicators, surveys to assess acquired and transmitted HIVDR, and development of an accredited HIVDR genotyping laboratory network to support survey implementation in resource-limited settings. As of June 2011, 52 countries had implemented at least 1 element of the strategy, and 27 laboratories had been accredited. As access to antiretrovirals expands under the WHO/Joint United Nations Programme on HIV/AIDS Treatment 2.0 initiative, it is essential to strengthen HIVDR surveillance efforts in the face of increasing concern about HIVDR emergence and transmission.

引用

页码：S245 / S249

页数：5

共 50 条

[21] New definitions of extensively drug resistant tuberculosis: update from the World Health Organization
Viney, Kerri
Mirzayev, Fuad
Linh, Nguyen Nhat
Gegea, Medea
Zignol, Matteo
EUROPEAN RESPIRATORY JOURNAL, 2021, 58
[22] Monitoring HIV Drug Resistance Early Warning Indicators in Cameroon: A Study Following the Revised World Health Organization Recommendations
Fokam, Joseph
Elat, Jean-Bosco N.
Billong, Serge C.
Kembou, Etienne
Nkwescheu, Armand S.
Obam, Nicolas M.
Essiane, Andre
Torimiro, Judith N.
Ekanmian, Gatien K.
Ndjolo, Alexis
Shiro, Koulla S.
Bissek, Anne C. Z-K.
PLOS ONE, 2015, 10 (06):
[23] HIV Drug Resistance Early Warning Indicators in Cohorts of Individuals Starting Antiretroviral Therapy Between 2004 and 2009: World Health Organization Global Report From 50 Countries
Bennett, Diane E.
Jordan, Michael R.
Bertagnolio, Silvia
Hong, Steven Y.
Ravasi, Giovanni
McMahon, James H.
Saadani, Ahmed
Kelley, Karen F.
CLINICAL INFECTIOUS DISEASES, 2012, 54 : S280 - S289
[24] World Health Organization-defined eosinophilic disorders: 2011 update on diagnosis, risk stratification, and management
Gotlib, Jason
AMERICAN JOURNAL OF HEMATOLOGY, 2011, 86 (08) : 678 - 688
[25] Genotyping External Quality Assurance in the World Health Organization HIV Drug Resistance Laboratory Network During 2007-2010
Parkin, Neil
Bremer, James
Bertagnolio, Silvia
CLINICAL INFECTIOUS DISEASES, 2012, 54 : S266 - S272
[26] Surveillance of transmitted and acquired HIV drug resistance using World Health Organization survey methods in resource-limited settings
Jordan, M. R.
Parkin, N.
Bertagnolio, S.
ANTIVIRAL THERAPY, 2011, 16 : A41 - A41
[27] Country adaptation of the 2010 World Health Organization recommendations for the prevention of mother-to-child transmission of HIV
Ghanotakis, Elena
Miller, Lior
Spensley, Allison
BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2012, 90 (12) : 921 - 931
[28] The 2019 World Health Organization Classification of appendiceal, colorectal and anal canal tumours: an update and critical assessment
Ahadi, Mahsa
Sokolova, Anna
Brown, Ian
Chou, Angela
Gill, Anthony J.
PATHOLOGY, 2021, 53 (04) : 454 - 461
[29] Transmitted HIV Drug Resistance Among Drug-Naive Subjects Recently Infected With HIV in Mexico City: A World Health Organization Survey to Classify Resistance and to Field Test Two Alternative Patient Enrollment Methods
Bertagnolio, Silvia
Rodriguez-Diaz, Roberto A.
Fuentes-Romero, Luis L.
Bennett, Diane E.
Viveros-Rogel, Monica
Hart, Stephen
Pilon, Richard
Sandstrom, Paul
Soto-Ramirez, Luis E.
CLINICAL INFECTIOUS DISEASES, 2012, 54 : S328 - S333
[30] New treatment outcome definitions for drug-susceptible and drug-resistant tuberculosis: update from World Health Organization
Nguyen, Nhat Linh
Mirzayev, Fuad
Viney, Kerri
Gegia, Medea
Zignol, Matteo
EUROPEAN RESPIRATORY JOURNAL, 2021, 58

← 1 2 3 4 5 →